Welcome to the Institute for Diabetes, Obesity and Metabolism
and Penn Diabetes Research Center

The IDOM was established in 2005 to address the ever increasing prevalence of diabetes and obesity. In 2016, there were 29.1 million people with diabetes in the United States, and more than one-third of U.S. adults are obese. In 2012, the cost of diabetes was estimated at $245 billion per year, and the Centers for Disease Control has projected that one out of three children born in the year 2000 will develop diabetes in his or her lifetime.

The mission of the IDOM is to support and develop successful approaches to the prevention, treatment, and cure of diabetes mellitus and obesity.

Learn more about IDOM and DRC >>

Recent News

Molecular Pilot Light Prepares Body’s Heating System For the Cold

Penn Animal Study Discovers New Molecular Player in Burning Sugar and Fat to Boost Metabolism

Read More


18 to 30: The Under-Recognized At Risk Patient Population

Shivani Agarwal, MD, MPH“Patients in the 18 to 30 age range, the ‘transition ages,’ often find themselves without primary care physicians, without the resources or time to manage their pre-existing conditions, and often without the awareness to effectively manage their own care,” said Shivani Agarwal, MD, MPH

Learn More


National Academy of Sciences Members and Foreign Associates Elected

Congratulations to Dr. Mitchell A. Lazar for being among the 84 newly elected members of of The National Academy of Sciences in recognition of their distinguished and continuing achievements in original research.

Learn More


Seminars & Events

Robert Margolskee, MD, PhD


Recent Publications

Complex Biology of Hyperinsulinism May Offer Cluses to Better Treatment.

Analyzing insulin-producing pancreatic cells from children with congenital hyperinsulinism (HI), CHOP endocrinology experts Diva De Leon, MD and Changhon Li, MD, PhD have discovered patterns of metabolic function and gene expression that may lay the groundwork for potential new treatments for this rare disease. Read More.